Skip to main content

Table 1 Detailed information about the participants and the measurements for the cytometries used in the experiments

From: optimalFlow: optimal transport approach to flow cytometry gating and population matching

 

Center

Final diagnosis

Tested sample

Coagulant

Sex

Age

Incubation period

Flow cytometer

\({\mathcal {C}}^{1}\)

1

HD

PB

EDTA

M

53

30

BD FACSCanto

\({\mathcal {C}}^{2}\)

1

HD

PB

EDTA

M

50

30

BD FACSCanto

\({\mathcal {C}}^{3}\)

1

HD

PB

EDTA

M

61

30

BD FACSCanto

\({\mathcal {C}}^{4}\)

2

HD

PB

Heparin

M

29

30

BD FACSCanto

\({\mathcal {C}}^{5}\)

2

HD

PB

Heparin

M

38

30

BD FACSCanto

\({\mathcal {C}}^{6}\)

2

HD

PB

Heparin

F

27

30

BD FACSCanto

\({\mathcal {C}}^{7}\)

2

HD

PB

Heparin

F

NA

30

BD FACSCanto

\({\mathcal {C}}^{8}\)

2

HD

PB

Heparin

M

NA

30

BD FACSCanto

\({\mathcal {C}}^{9}\)

2

HD

PB

Heparin

F

NA

30

BD FACSCanto

\({\mathcal {C}}^{10}\)

2

HD

PB

Heparin

F

NA

30

BD FACSCanto

\({\mathcal {C}}^{11}\)

3

HD

PB

NA

M

34

15

BD FACSCanto

\({\mathcal {C}}^{12}\)

3

HD

PB

NA

F

33

15

BD FACSCanto

\({\mathcal {C}}^{13}\)

3

HD

PB

NA

M

32

15

BD FACSCanto

\({\mathcal {C}}^{14}\)

3

HD

PB

NA

M

33

15

BD FACSCanto

\({\mathcal {C}}^{15}\)

3

HD

PB

NA

F

35

15

BD FACSCanto

\({\mathcal {C}}^{16}\)

3

HD

PB

EDTA

NA

Adult

15

BD FACSCanto

\({\mathcal {C}}^{17}\)

3

HD

PB

EDTA

NA

Adult

15

BD FACSCanto

\({\mathcal {C}}^{18}\)

3

HD

PB

EDTA

NA

Adult

15

BD FACSCanto

\({\mathcal {C}}^{19}\)

3

HD

PB

EDTA

NA

Adult

15

BD FACSCanto

\({\mathcal {C}}^{20}\)

3

HD

PB

EDTA

NA

Adult

15

BD FACSCanto

\({\mathcal {C}}^{21}\)

NA

HD

NA

NA

NA

NA

NA

BD FACSCanto

\({\mathcal {C}}^{22}\)

4

MCL

PB

NA

F

82

15

BD FACSCanto

\({\mathcal {C}}^{23}\)

4

MCL

PB

NA

M

70

15

BD FACSCanto

\({\mathcal {C}}^{24}\)

4

FL

BM

NA

M

52

15

BD FACSCanto

\({\mathcal {C}}^{25}\)

4

MCL

BM

NA

M

81

15

BD FACSCanto

\({\mathcal {C}}^{26}\)

4

LPL

PB

NA

M

67

15

BD FACSCanto

\({\mathcal {C}}^{27}\)

1

CLL

LN

Other

F

61

30

BD FACSCanto

\({\mathcal {C}}^{28}\)

1

CLL

LN

Other

F

61

30

BD FACSCanto

\({\mathcal {C}}^{29}\)

1

HD

PB

EDTA

F

27

30

BD FACSCanto

\({\mathcal {C}}^{30}\)

1

HD

PB

EDTA

M

54

30

BD FACSCanto

\({\mathcal {C}}^{31}\)

1

HD

PB

EDTA

M

50

30

BD FACSCanto

\({\mathcal {C}}^{32}\)

1

HD

PB

EDTA

F

36

30

BD FACSCanto

\({\mathcal {C}}^{33}\)

1

HD

PB

EDTA

M

74

30

BD FACSCanto

\({\mathcal {C}}^{34}\)

1

DLBCL

Other

Other

M

65

30

BD FACSCanto

\({\mathcal {C}}^{35}\)

1

HCL

BM

EDTA

M

40

30

BD FACSCanto

\({\mathcal {C}}^{36}\)

2

HD

PB

Heparin

M

38

30

BD FACSCanto

\({\mathcal {C}}^{37}\)

2

HD

PB

Heparin

F

27

30

BD FACSCanto

\({\mathcal {C}}^{38}\)

2

HD

PB

Heparin

M

NA

30

BD FACSCanto

\({\mathcal {C}}^{39}\)

2

HD

PB

Heparin

F

NA

30

BD FACSCanto

\({\mathcal {C}}^{40}\)

3

HD

PB

EDTA

NA

NA

15

BD FACSCanto

  1. Samples come from four international centers labelled as 1–4. Diagnosis abbreviations correspond to: healthy diagnosis, mantle cell lymphoma, follicular lymphoma, lymphoplasmacytic lymphoma, chronic lymphocytic leukemia, diffuse large B-cell lymphoma and hairy cell leukemia. The abbreviations for the type of tested samples correspond to: peripherial blood, bone marrow, lymph node. Coagulant refers to the type of coagulant used for preservation of the sample. The incubation period is measured in minutes